The 4th EACTS Mechanical Circulatory Support Summit will run from 7-9 November 2019
THURSDAY 7 NOVEMBER (08:00-18:00)
| 08:00 | Welcome | V Falk, Berlin; J Gummert, Bad Oeynhausen; I Netuka, Prague |
| 08:15 | Session 1: A heart failure therapy continuum and transplantation conundrums |
|
| Moderators: V Falk, Berlin; J Gummert, Bad Oeynhausen; G Stewart, Boston | ||
| Drugs, clips and LVADs: How to avoid a disconnect in heart failure therapies | U Jorde, New York | |
| Tablets on top of LVADs – what is an optimal medical therapy after the implant? | M Cikes, Zagreb | |
| Lessons learned from the new UNOS allocation system | F Pagani, Ann Arbor | |
| Direct ECMO to heart transplantation strategy, the European experience | P Leprince, Paris | |
| Panel discussion | ||
| 10:00 | Break | |
| 10:30 | EACTS MCS Lifetime Recognition Award to be received by Professor J Pirk (Prague) | |
| Moderators: V Falk, Berlin; J Gummert, Bad Oeynhausen; M Mehra, Boston | ||
| Accomplishments overview by I Netuka | ||
| 10:45 | Session 2: Registries, guidelines and upcoming endeavours |
|
| Moderators: R Cogswell, Minneapolis; M Mehra, Boston; I Netuka, Prague | ||
| Europe, Quo Vadis? – the EUROMACS report | T De By, The Hague | |
| Pearls and diamonds of the EACTS Expert Consensus on MCS | F Gustafsson, Copenhagen | |
| What has IMACS taught us about patient outcomes with durable MCS? | J Cowger, Detroit | |
| Inferences of the MEDAMACS on an optimal timing of an LVAD implant | G Stewart, Boston | |
| Panel discussion | ||
| Featured lecture: Artificial intelligence, machine learning and beyond – Implications for cardiovascular medicine | A Meyer, Berlin | |
| 12:15 | Lunch | |
| 13:15 | Session 3: Joint EACTS MCS & EURO-ELSO Scientific Symposium |
|
| Moderators: J Belohlavek, Prague; A Bernhardt, Hamburg; P Ostadal, Prague | ||
| Extended cardiopulmonary resuscitation (CPR) for refractory cardiac arrest | J Belohlavek, Prague | |
| New arms for cardiopulmonary resuscitation: Light at the end of the tunnel? | C Benk, Freiburg | |
| Venoarterial (VA) ECLS in cardiogenic shock – still an ongoing debate | S Finney, London | |
| Different ECLS configurations in postcardiotomy shock | R Lorusso, Maastricht | |
| Direct transition from ECLS to durable LVADs | F Hennig, Berlin | |
| Panel discussion | ||
| 14:45 | Session 4: Changing paradigms in cardiogenic shock – New tools, ground-breaking strategies |
|
| Moderators: C Antonides, Rotterdam; U Jorde, New York; D Schibilsky, Freiburg | ||
| Staged escalation of transaortic left ventricular unloading – a partial flow is good enough | F Pappalardo, Milan | |
| ECLS de-escalation strategies with transaortic MCS – full flow ahead | D Saeed, Leipzig | |
| Optimal device selection in cardiogenic shock – I do it my way | E Potapov, Berlin | |
| A quest towards longer-term transaortic MCS – promises and perils | A Bernhardt, Hamburg | |
| Panel discussion | ||
| 16:15 | Break | |
| 16:45 | Session 5: Novel integrated approaches and technologies in MCS space |
|
| Moderators: V Falk, Berlin; M Mehra, Boston; H Reichenspurner, Hamburg | ||
| Should we transplant stable LVAD patients – if yes when is the best time for it? | H Reichenspurner, Hamburg | |
| A wealth of data and clinical implications of LVAD log files | T Schlöglhofer, Vienna | |
| Towards a physiological flow LVAD – closest to the finish line? | M Mehra, Boston | |
| A true need for permanent wearables in LVADs? A new reality of unholstered device operation | M Zilberschlag, Tel Aviv | |
| What will the next generation LVAD look like? | K Bourque, Burlington | |
| Panel discussion | ||
| 18:15 | Close | |
| Welcome reception (18:15-19:30) |
FRIDAY 8 NOVEMBER (08:00-18:45)
| 08:00 | Session 1: Perioperative challenges and evolving implant strategies |
|
| Moderators: H Gasparovic, Zagreb; R John, Minneapolis; P Lanmueller, Berlin | ||
| How should we optimise with redo cases? Tricks and caveats | M Morshuis, Bad Oeynhausen | |
| Indications for intervention to manage aortic insufficiency – perioperative and on support | R John, Minneapolis | |
| Durable LVAD exchanges and upgrades | J Schmitto, Hannover | |
| Cardiopulmonary bypass in oblivion – ECLS facilitated LVAD implant | G Färber, Jena | |
| Cardiopulmonary bypass in oblivion – transaortic MCS facilitated LVAD implant | D Zimpfer, Vienna | |
| Off-pump LVAD implant. Is there a right time for a primetime? | E Potapov, Berlin | |
| Panel discussion | ||
| 09:30 | Session 2: Hemocompatibility – a new established entity in MCS landscape |
|
| Moderators: J Cowger, Detroit; F Gustafsson, Copenhagen; Z Tucanova, Prague | ||
| Hemocompatibility related adverse events | M Mehra, Boston | |
| Strokes and LVADs – characteristic features and treatment strategies | C Schulze, Jena | |
| Indication of dependent and independent vitamin K antagonist (VKA) withdrawal in contemporary LVADs | I Netuka, Prague | |
| The future of LVAD therapy through the lens of a hematologist | J M Connors, Boston | |
| Panel discussion | ||
| 10:40 | Break | |
| 11:00 | Session 3: The judgement of Paris: How do I choose the optimal pump for my patients? |
|
| Moderators: G Färber, Jena; J Gummert, Bad Oeynhausen; F Pagani, Ann Arbor | ||
| Presentation 1 | J Lavee, Tel Aviv | |
| Presentation 2 | C Mahr, Seattle | |
| Presentation 3 | C Selzman, Salt Lake City | |
| Panel discussion | ||
| 12:00 | Keynote: Integrative approach in overcoming residual risks of LVADs towards the equipoise with the heart transplant | M Mehra, Boston |
| 12:30 | Lunch | |
| 13:30 | 4th Rising Stars Quiz | I Netuka, Prague; E Potapov, Berlin |
| 14:30 | Session 4: The right ventricle challenge |
|
| Moderators: J Eulert-Grehn, Berlin; J Katz, Chapel Hill; J Stehlik, Salt Lake City | ||
| Longitudinal performance of the right ventricle through a magnifying glass | V Melenovsky, Prague | |
| Right ventricular (RV) failure – isolated issue or a peril of interwoven complexity? | E Rame, Pennsylvania | |
| Evolving trends in treatment of early RV failure | D Schibilsky, Freiburg | |
| Late right ventricular failure – now what? | R Schramm, Bad Oeyenhausen | |
| Panel discussion | ||
| 15:35 | Session 5: Boon and bane of biventricular MCS solutions – when both ventricles are done |
|
| Moderators: F Khaliel, Riyadh; M Morshuis, Bad Oeynhausen; Y Pya, Astana | ||
| Chronic biventricular solution indications: Who, When, How? | J Katz, Chapel Hill | |
| RV dysfunction: Biventricular continuous flow pumps, total artificial heart (TAH) or paracorporeal devices – what is better? | J Gummert, Bad Oeynhausen | |
| Results with TAH are not superior to BiVAD in patients with severe RV dysfunction | R John, Minneapolis | |
| New TAH alternatives: Pulsatile or continuous flow? | P Ivak, Prague | |
| Panel discussion | ||
| 16:30 | Break | |
| 16:50 | Session 6: From the new world: Unorthodox and creative solutions – How to get into or out of trouble |
|
| Moderators: J Garbade, Leipzig; E Potapov, Berlin; D Zimpfer, Vienna | ||
| Presentation 1 | R John, Minneapolis | |
| Presentation 2 | F Pagani, Ann Arbor | |
| Presentation 3 | C Selzman, Salt Lake City | |
| 17:20 | Session 7: Cardiac reverse remodelling and recovery in MCS – State of the art |
|
| Moderators: C Mahr, Seattle; A Meyer, Leipzig; C Selzman, Salt Lake City | ||
| Recovery on acute MCS – wait, wean or transition…When and how? | R Cogswell, Minneapolis | |
| LVAD explantation for cardiac recovery – who and when? | U Jorde, New York | |
| The role of mitral regurgitation in sustainable LV recovery – fix it, clip later or simply ignore | J Mulzer, Berlin | |
| Preliminary results of multicenter evaluation of plug use for LVAD explantation | E Potapov, Berlin | |
| The future of cardiac recovery in MCS space – 30 000 feet perspective | J Stehlik, Salt Lake City | |
| Panel discussion | ||
| 18:45 | Close |
SATURDAY 9 NOVEMBER (08:00-14:00)
| 08:00 | Session 1: Challenging populations and expanding horizons in heart failure landscape |
|
| Moderators: A Loforte, Bologna; J Pirk, Prague; J Vierecke, Cincinnati | ||
| Pitfalls of durable MCS in GUCH population | M Schweiger, Zurich | |
| Surgical planning in complex anatomies | B Meyns, Leuven | |
| Optimised utilization of potential donor hearts – ex-vivo graft reconditioning | R Venkateswaran, Manchester | |
| An ultimate frontier – DCD donor utilization for heart transplantation | S Tsui, Cambridge | |
| Panel discussion | ||
| 09:00 | Session 2: Electrons, leads, devices and arrhythmia management in MCS |
|
| Moderators: M Konarik, Prague; K Selzman, Salt Lake City; C Starck, Berlin | ||
| CIEDs in LVAD patients – PM, CRT, ICD | J Vierecke, Cincinnati | |
| Transvenous lead extraction in LVAD patients – when, why and how? | C Starck, Berlin | |
| Implantable cardiac monitoring systems in LVAD population | F Schönrath, Berlin | |
| Supraventricular and ventricular arrhythmia management in MCS recipients | J Kautzner, Prague | |
| Panel discussion | ||
| 10:00 | Break | |
| 10:30 | Session 3: Small improvements, a major impact? |
|
| Moderators: P Ivak, Prague; M Morshuis, Bad Oeynhausen; M Zembala, Zabrze | ||
| Thrombus formation around inflow canula of CF-Pumps – interplay of a position and hemodynamics | F Kaufmann, Berlin | |
| Optimising inflow cannula position by 3D preop rendering | I Hartyanszky, Budapest | |
| Background and outlook on the usage of cold atmospheric plasma (CAP) in medicine | K Masur, Greifswald | |
| CAP: An additive treatment option for critical wounds in cardiovascular surgery | L Hilker, Karlsburg | |
| CAP in critical driveline exit site infection therapy – (Case series) | M Konarik, Prague | |
| Panel discussion | ||
| 11:30 | Session 4: From the old world: Unorthodox and creative solutions – How to get into or out of trouble |
|
| Moderators: U Kervan, Ankara; P Nemec, Brno; J Schmitto, Hannover | ||
| Pericardial tamponade after LVAD implantation through left lateral thoracotomy | P Lanmueller, Berlin | |
| Presentation 2 | I Knezevic, Ljubljana | |
| Presentation 3 | G Gerosa, Padua | |
| Presentation 4 | A Loforte, Bologna | |
| Presentation 5 | M Morshuis, Bad Oeynhausen | |
| Presentation 6 | J Maly, Prague | |
| 12:30 | Session 5: Update of current and upcoming devices |
|
| 13:45 | Closing Remarks |
Programme and faculty subject to change
COURSE INFORMATION
Date/Duration
7-9 November 2019 (3 day course)
Location
Prague, Czech Republic
Please click HERE for more information
Chairmen
I Netuka, Prague; V Falk, Berlin and J Gummert, Bad Oeynhausen
Registration Fee
Members: €550 inclusive of VAT
Non-Members: €650 inclusive of VAT
Optional Dinner: €50 inclusive of VAT
Course fee includes lunch and refreshments on all days and the welcome reception on Thursday 7 November
Summit Format
Interactive lectures, live-in-a-box cases and keynote presentations
Target Audience
Cardiologists, heart failure cardiologists, emergency and ICU specialists (ECLS), cardiac surgeons, perfusionists, heart failure nurses and ventricular assist device (VAD) coordinators, medical industry (cardiac devices including ECMO development and production). Paediatric cardiologists and congenital heart disease surgeon.
Learning Objectives
- Learn about how to find the right treatment for the right patient at the right time
- Use of temporary MCS systems in emergency situations and in the ICU
- Learning of recommendations for VAD use from major societies and from recently published guidelines
- New surgical techniques for VAD implantation, as well as unusual solutions of complex surgical problems in VAD patients
- How to avoid long-term complications during VAD treatment
- Learn about shared care and the role of social media for VAD patients and caregivers
- Learn about myocardial recovery in children and adults
- Review and learn about the latest developments and perspectives in the VAD field
